Omphalitis in detail with causes, diagnosis, pathogenesis clinical features investigations management in case of 23 year old make patient

Reading File
Finding Sources
Finding Sources
Searching PubMed

omphalitis adults management

Searching the Web

omphalitis adult 23 year old causes pathogenesis clinical features diagnosis management

Reading File
Reading Article

PMID: 35082592

Reading Web Page

https://pmc.ncbi.nlm.nih.gov/articles/PMC8739386

Finding Sources
Finding Sources
Finding Sources
Finding Sources
Searching PubMed

omphalitis adults urachal remnant recurrent

Reading File
Reading Article

PMID: 41091184

I now have comprehensive information to write a detailed, well-organized answer. Let me synthesize everything.

Omphalitis - Comprehensive Clinical Review

(Adapted for a 23-Year-Old Male Patient)


Definition

Omphalitis is an infection/inflammation of the umbilicus and periumbilical soft tissues. While classically described as a neonatal condition (umbilical stump infection), it also occurs in adults - and a recent 2026 nationwide Japanese study (Tokunaga et al., Surgery Today, PMID 41091184) found that among 11,477 adult omphalitis patients, urachal remnants were present in 16% overall, with prevalence exceeding 30% in males aged 20-34 - making your patient's age and sex a high-risk demographic.

Anatomy Relevant to Adults

The umbilicus is the residual fibrous scar of the umbilical cord. In adults it normally has no patent connection to underlying structures. However, several embryological remnants can persist and predispose to infection:
RemnantConnectsClinical Risk
Patent urachusUmbilicus to bladder domeRecurrent omphalitis, abscess
Urachal cystMidline, no external openingInfected cyst presenting as omphalitis
Urachal sinusOpens at umbilicusDischarge, entry point for bacteria
Meckel's diverticulumIleum via vitelline ductRarely, enterocutaneous fistula

Causes and Predisposing Factors

Microbiology - Causative Organisms

Omphalitis is typically polymicrobial. The predominant pathogens are:
Gram-positive:
  • Staphylococcus aureus (most common; including CA-MRSA)
  • Streptococcus pyogenes (Group A Strep) - associated with necrotizing progression
  • Staphylococcus epidermidis
  • Enterococci
Gram-negative:
  • Escherichia coli
  • Klebsiella pneumoniae
  • Proteus mirabilis
  • Pseudomonas aeruginosa (immunocompromised)
Anaerobes (in mixed/type II necrotizing infections): Bacteroides spp., anaerobic streptococci

Risk Factors in a 23-Year-Old Male

CategorySpecific Factors
AnatomicalUrachal remnant (>30% prevalence in this age-sex group), umbilical hernia, deep umbilical recess (hygiene difficulty)
HygienePoor periumbilical cleaning, infrequent bathing, body piercing at umbilicus
Skin disruptionUmbilical piercing (very common in young adults), trauma, abrasion
ImmunodeficiencyLeukocyte adhesion deficiency (LAD), neutropenia, HIV, diabetes mellitus, corticosteroid use
ObesityDeep, moist umbilical fold - creates maceration and bacterial overgrowth
Previous surgeryLaparoscopic port site at umbilicus
InflammatoryCrohn's disease (enterocutaneous fistula presenting at umbilicus)

Pathogenesis

Step 1 - Colonization: Bacteria colonize the moist, protected umbilical recess. In adults with deep or folded umbilici (obesity, poor hygiene), the microenvironment is warm, occluded, and moist - ideal for bacterial overgrowth.
Step 2 - Breach of epithelial barrier: A small abrasion, piercing, maceration, or minor trauma breaks the skin. In patients with a urachal sinus or patent urachus, bacteria enter via the patent tract connecting the bladder to the umbilicus (urinary contamination with gram-negative organisms is especially likely in males via ascending urinary flora).
Step 3 - Local invasion: Bacteria penetrate the dermis and subcutaneous tissue, triggering an inflammatory response - erythema, edema, warmth, purulent discharge.
Step 4 - Spread along fascial planes: The loose areolar tissue around the umbilicus offers little resistance. Infection spreads:
  • Superficially → cellulitis, lymphangitis
  • Deep → along fascial planes → necrotizing fasciitis (the most feared complication)
  • Via portal circulation → portal pyemia → pyogenic liver abscess (omphalitis is a recognized cause via the obliterated umbilical vein/portal circulation - Rosen's Emergency Medicine)
  • Systemically → bacteremia → sepsis
Key immunological note - LAD (Leukocyte Adhesion Deficiency): In LAD type I (ITGB2 mutation encoding CD18), neutrophils cannot adhere to endothelium and migrate to infection sites. Recurrent omphalitis in young adults should prompt evaluation for LAD. A hallmark feature is delayed umbilical cord separation (>21 days) in infancy and subsequent recurrent umbilical infections. - Cellular and Molecular Immunology and Emery's Elements of Medical Genetics

Clinical Features

Grading of Omphalitis (Modified)

GradeExtentFeatures
MildLocalizedErythema <2 cm, minimal periumbilical involvement, no systemic signs
ModeratePeriumbilical cellulitisErythema >2 cm, induration, purulent/malodorous discharge, low-grade fever
SevereDeep/fascial spreadCrepitus, skin discoloration (purple/black), bullae, high fever, tachycardia, sepsis

Symptoms in a 23-Year-Old Male

Local (early):
  • Periumbilical erythema, warmth, swelling
  • Tenderness around the umbilicus
  • Purulent (yellow-green), seropurulent, or malodorous discharge from the umbilicus
  • Induration of periumbilical skin
Local (advanced):
  • Fluctuance - abscess formation
  • Skin color changes: violaceous, dark-red, then black (indicates deep necrosis)
  • Crepitus on palpation (gas-forming organisms, necrotizing fasciitis)
  • Skin blistering or bullae
  • Lymphangitic streaking on abdominal wall
Systemic:
  • Fever (may be high-grade in severe cases)
  • Tachycardia, hypotension (sepsis/toxic shock)
  • Nausea, vomiting, abdominal pain
Signs pointing to underlying urachal pathology (important in 23M):
  • History of recurrent umbilical discharge
  • Clear/cloudy (urine-like) discharge from umbilicus
  • Cyclical discharge with bladder filling
  • Palpable midline mass between umbilicus and pubic symphysis

Investigations

Bedside/Laboratory

InvestigationRationaleExpected Findings
Complete Blood Count (CBC)Assess systemic infection, WBC countLeukocytosis (>11,000/mm³), neutrophilia, left shift
CRP / ESRInflammatory markersElevated; very high CRP suggests deep/necrotizing infection
Blood culture (×2)Before antibiotics - detect bacteremiaMay isolate causative organism
Wound swab/discharge culture + sensitivityIdentifies specific pathogen, guides targeted therapyPolymicrobial; staph, strep, gram-negatives
Gram stain of dischargeRapid morphological clueGram-positive cocci vs. gram-negative rods
Blood glucose / HbA1cRule out diabetes (major risk factor)Normal or elevated
Urinalysis + urine cultureIf urachal pathology suspected - may show WBCs, bacteriaPyuria/bacteriuria if patent urachus
LFTs, RFTsBaseline organ function; monitor sepsisMay show elevated transaminases in portal spread
Serum lactateIf sepsis suspected>2 mmol/L indicates tissue hypoperfusion
Coagulation profile (PT/INR, APTT)DIC in severe sepsisProlonged in DIC

Imaging

ModalityWhen to UseFindings
Ultrasound (USS) abdomen/umbilical regionFirst-line imagingThickening of subcutaneous fat and fascia, fluid collection, abscess, midline tubular structure (urachal remnant appearing as hypoechoic elliptical structure)
CT Abdomen and Pelvis (with contrast)Moderate-severe disease, suspected deep extension, urachal pathology, or abscessDefines extent of fascia involvement, detects gas (necrotizing fasciitis), characterizes urachal remnant/cyst, abscesses, peritoneal extension
MRI Abdomen/PelvisIf radiation concern; better soft tissue detailExcellent for soft tissue planes; detects urachal cysts
Sinogram/FistulogramIf umbilical sinus/fistula presentDelineates tract anatomy
Key imaging points for this patient:
  • Ultrasound can show an elliptical hypoechoic midline structure between umbilicus and pubic symphysis - diagnostic of urachal remnant
  • CT scan is the modality of choice to determine muscle/fascial involvement in severe cases and to rule out necrotizing fasciitis
  • Given he is a young male aged 23 with omphalitis, early imaging is recommended per the 2026 Japanese nationwide study (Tokunaga et al., Surgery Today 2026)

Differential Diagnosis

ConditionDistinguishing Features
Umbilical granulomaPink, granular polyp at umbilicus; no surrounding cellulitis; responds to silver nitrate
Umbilical hernia with incarcerationReducible/irreducible mass; bowel sounds in swelling; no purulent discharge
Urachal cyst (uninfected)Midline mass below umbilicus; no erythema
Folliculitis / carbuncleLocalized follicular pustule; no spreading cellulitis
Pilonidal cystUsually sacrococcygeal; rarely umbilical
Crohn's disease enterocutaneous fistulaHistory of IBD; fecal material in discharge; colonoscopy/CT enterography findings
Necrotizing fasciitisRapid progression, crepitus, "wooden hard" feel, disproportionate pain; surgical emergency
Desmoid tumor / soft tissue neoplasmNon-inflammatory firm mass; no fever
Sister Mary Joseph noduleHard, fixed, painless; represents intra-abdominal malignancy metastasis

Management

Principles: Risk-stratify based on severity


Mild Omphalitis (Localized cellulitis, no systemic signs)

Outpatient management:
  1. Topical antiseptics: Chlorhexidine 0.5-2% applied twice daily to the umbilical area
  2. Oral antibiotics (empiric, pending culture):
    • First-line: Amoxicillin-clavulanate 875/125 mg twice daily for 7-10 days (covers gram-positives and some gram-negatives)
    • Alternative: Cefalexin 500 mg four times daily (if gram-positive dominant presentation)
    • If MRSA suspected (e.g., prior colonization, failed beta-lactam): Trimethoprim-sulfamethoxazole (TMP-SMX) 160/800 mg twice daily or doxycycline 100 mg twice daily
  3. Hygiene: Keep area clean and dry; avoid occlusive clothing
  4. Review at 48-72 hours: If not improving, escalate to inpatient IV therapy

Moderate Omphalitis (Periumbilical cellulitis, low-grade fever, no sepsis)

Inpatient admission:
  1. IV antibiotics (empiric):
    • Flucloxacillin 1-2g IV 4-6 hourly + Metronidazole 500 mg IV 8 hourly
    • OR Piperacillin-tazobactam 4.5 g IV 8 hourly (good polymicrobial cover)
    • Adjust to culture and sensitivity results within 48-72 hours
    • If MRSA risk: add Vancomycin 15-20 mg/kg IV 12 hourly (with TDM)
  2. Supportive care:
    • IV fluids if dehydrated
    • Analgesics (paracetamol, NSAIDs or opioids as appropriate)
    • Mark the margin of erythema with a skin marker pen at presentation to monitor spread
  3. Imaging: USS umbilical region urgently to rule out abscess/urachal remnant
  4. If abscess present: Incision and drainage (I&D) under local anesthesia

Severe Omphalitis (Abscess, fasciitis, systemic sepsis)

ICU-level care:
  1. Sepsis bundle (within 1 hour):
    • Blood cultures ×2 before antibiotics
    • Serum lactate
    • IV fluid resuscitation: 30 mL/kg crystalloid bolus
    • Broad-spectrum IV antibiotics immediately
  2. Antibiotics for severe/septic omphalitis:
    • Meropenem 1g IV 8 hourly + Vancomycin 15-25 mg/kg IV (for MRSA cover)
    • OR Piperacillin-tazobactam 4.5g IV 6-8 hourly + Vancomycin
    • Duration: 10-14 days IV, then step down to oral based on culture
  3. Surgical management (critical for necrotizing fasciitis):
    • Necrotizing fasciitis is a surgical emergency - prompt wide surgical debridement of all necrotic tissue
    • Return to theatre every 24-48 hours until wound is clean ("second look")
    • Wound left open for secondary closure or skin grafting after clearance
    • Mortality is high if surgery delayed - do not wait for imaging if clinical features are clear
    • Harrison's Principles of Internal Medicine, p.1096 emphasizes that late-stage necrotizing fasciitis with purple bullae, skin sloughing, and shock demands immediate surgical exploration
  4. Two-stage approach for urachal remnant-associated omphalitis (based on Tawk et al., Case Rep Gastroenterol 2021):
    • Stage 1: IV antibiotics (penicillin + aminoglycoside, or broader spectrum) for 10 days + I&D of any abscess
    • Stage 2: Elective surgical resection of the urachal remnant (laparoscopic preferred since 2018 per Tokunaga et al. 2026) - prevents recurrence; median time to surgery ~2 months

Antibiotic Summary Table

SeveritySettingRegimen
MildOutpatientAmoxicillin-clavulanate PO 7-10 days
ModerateInpatientPiperacillin-tazobactam IV or Flucloxacillin + Metronidazole IV
Severe/SepticICUMeropenem + Vancomycin IV; surgical debridement if necrotizing
MRSA suspectedAnyAdd TMP-SMX (oral) or Vancomycin (IV)
Urachal remnant2-stagedAntibiotics → I&D → elective laparoscopic urachal excision

Complications

ComplicationNotes
Necrotizing fasciitisMost feared; spreads rapidly along abdominal wall fascial planes; requires emergency surgery
Sepsis / Septic shockSystemic bacteremia; multi-organ failure
PeritonitisDeep extension through abdominal wall
Pyogenic liver abscessVia portal circulation; E. coli and Klebsiella most common organisms - Rosen's Emergency Medicine
Umbilical abscessLocalized pus collection; requires I&D
RecurrenceStrongly associated with urachal remnant if not resected
Portal vein thrombosis / hepatic vein thrombosisRare; from bacterial seeding of portal vasculature
Urachal carcinomaRare (0.054%) but documented long-term complication of untreated urachal remnant - Tokunaga et al. 2026

Special Consideration for This Patient (23-Year-Old Male)

  1. Urachal remnant is the most likely underlying cause - must be excluded with ultrasound and CT. The 2026 Japanese claims database study found >30% prevalence of urachal remnants specifically in males aged 20-34 with omphalitis. Without excision, recurrence is likely.
  2. Umbilical piercing is a common precipitant in young adults - ask about this in history.
  3. LAD (Leukocyte Adhesion Deficiency) should be considered if this is a recurrent presentation or if there is a history of delayed umbilical cord separation as a neonate, recurrent skin/mucosal infections, or poor wound healing. Workup includes flow cytometry for CD18/CD11b expression on neutrophils.
  4. If any crepitus, disproportionate pain, rapid spread, or toxicity is present - treat as necrotizing fasciitis from the outset; do not wait. The mortality from missed necrotizing fasciitis far exceeds the morbidity of exploratory surgery.
  5. Antibiotic stewardship: Always obtain culture before starting antibiotics. Step down from IV to oral within 48-72 hours once the patient is clinically improving and tolerating oral intake.

Key References

Patient is Obese and non diabetic and normotensive

Great additional context. Obesity significantly changes the clinical picture for this patient. Let me refine the analysis specifically for an obese, non-diabetic, normotensive 23-year-old male.

Omphalitis in an Obese 23-Year-Old Male (Non-Diabetic, Normotensive)


How Obesity Specifically Drives Omphalitis in This Patient

Obesity is one of the strongest independent risk factors for omphalitis in adults, and it operates through several distinct mechanisms:

1. Anatomical - The "Deep Umbilicus" Effect

In obese individuals, the umbilicus is characteristically:
  • Deeply recessed into a panniculus of adipose tissue
  • Surrounded by overhanging skin folds that create a closed, occluded microenvironment
  • This traps sweat, desquamated keratin, moisture, and sebum - creating the ideal culture medium for polymicrobial growth
  • The skin-on-skin contact causes maceration (softening/breakdown of epithelium), breaching the first line of defense

2. Impaired Local Perfusion

  • Thick adipose tissue reduces cutaneous blood supply to the umbilical region
  • Poorer perfusion = slower neutrophil delivery = slower local immune response
  • Also delays recognition of early infection signs (erythema may be harder to detect through dark/thick skin)

3. Impaired Wound Healing

  • Adipose tissue is relatively avascular and hypoxic
  • Hypoxia impairs neutrophil oxidative burst (respiratory burst) - the primary mechanism bacteria are killed
  • Even without diabetes, obese patients have impaired healing due to adipokine dysregulation (altered leptin, adiponectin signaling)

4. Pro-inflammatory / Immunomodulatory State

  • Obesity produces a chronic low-grade inflammatory state with elevated IL-6, TNF-α, CRP
  • This paradoxically blunts the acute immune response to new infection
  • Dysregulated macrophage function in obese adipose tissue reduces effective bacterial clearance

5. Mechanical - Hygiene Difficulty

  • The deep umbilical recess is physically difficult to clean in an obese patient
  • Deodorant, soap, and rinse water do not penetrate effectively
  • Umbilical debris accumulates as omphaloliths (umbilical stones/navel stones) - compacted keratin, sebum, and bacteria that serve as a nidus for infection

6. Greater Risk of Serious Complications

  • Necrotizing fasciitis spreads faster and more extensively in obese patients because:
    • More adipose tissue to traverse along fascial planes
    • Thicker abdominal wall makes early recognition of crepitus harder to detect
    • Greater distance between skin surface and fascia delays appreciation of deep involvement on examination
    • Blood supply compromise already present → faster tissue necrosis

Modified Clinical Assessment for This Obese Patient

History - Key Questions to Ask

DomainQuestions
OnsetHow long has the redness/discharge been present? Did it start suddenly or gradually?
HygieneDo you clean inside your umbilicus? How often do you bathe? Any visible "debris" or "dark material" inside?
DischargeWhat color is the discharge - yellow/green (pus), clear/cloudy (possibly urine from patent urachus), or brown (possibly fecal - Crohn's fistula)?
PainIs the pain out of proportion to what you see? (Disproportionate pain = necrotizing fasciitis until proven otherwise)
PiercingDo you have or have you ever had an umbilical piercing?
SystemicAny fever, chills, rigors? Nausea/vomiting?
RecurrenceHas this happened before? (Suggests urachal remnant)
Urinary symptomsAny discharge when you urinate? Any cyclical umbilical wetness? (Patent urachus)
Bowel symptomsAny IBD diagnosis or change in bowel habits? (Enterocutaneous fistula)

Physical Examination - Obesity-Specific Considerations

Examination StepObesity-Specific Note
Expose umbilicus fullyLift the panniculus - do not assess with patient simply lying flat; use a bright light source
Erythema marginsMark with a skin pen at time of assessment; difficult to see on darker or thick skin but critical for monitoring progression
Palpation for fluctuanceHarder through thick adipose tissue - do not rely on palpation alone; USS is essential
CrepitusActively palpate widely; may be felt only deep in the tissue fold
Depth of recessNote presence of omphalolith (dark, compacted debris inside umbilicus)
Extent of cellulitisMeasure and document distance of erythema from umbilical center
Skin integrityLook for maceration, satellite erosions, intertrigo in umbilical fold
Lymph nodesCheck inguinal nodes (drain lower abdominal wall)
Abdominal wallAny rigidity, guarding, or peritonism suggesting deep extension

Investigations - Modified for This Patient

Additional/Modified Tests vs. Standard Patient

InvestigationRationale Specific to Obese Patient
HbA1c and fasting glucoseEven though non-diabetic now - obese patients have insulin resistance; subclinical hyperglycemia worsens infection; pre-diabetes must be excluded
Fasting lipid profileMetabolic workup - obesity-associated dyslipidemia affects immune function
Ultrasound (mandatory, not optional)Clinical examination is unreliable in obesity - palpation alone may miss deep abscess; USS is the minimum standard
CT abdomen/pelvis (low threshold)More readily indicated in obese patients - clinical assessment less reliable; essential to define extent and detect urachal remnant
BMI and waist circumferenceDocument formally; relevant for surgical planning (anaesthetic risk, wound closure, drain placement)
LFTs / serum albuminLow albumin is common in "metabolically unhealthy obese" patients; hypoalbuminaemia significantly impairs wound healing and increases surgical risk
CRP / procalcitoninBaseline CRP is elevated in obesity; use serial measurements for trend rather than single value; procalcitonin >0.5 mcg/L suggests bacterial systemic infection

Management - Modified for Obese Patient

Wound / Umbilical Care (Unique to Obesity)

  1. Omphalolith removal: If a compacted umbilical stone is present, it must be removed (often requires softening with a few drops of hydrogen peroxide or saline, then gentle extraction with cotton-tipped applicator). Leaving it in place perpetuates infection.
  2. Drying the umbilical recess: After each clean, use a hair dryer on cool setting or rolled gauze to ensure the deep umbilical fold is completely dry - moisture is the enemy.
  3. Intertrigo management in surrounding skin folds: Treat macerated periumbilical skin with barrier cream (zinc oxide) and antifungal powder if co-infection with Candida is suspected (white plaques, satellite lesions).
  4. Positioning: Elevate the panniculus with an abdominal binder or tape to reduce skin-on-skin contact during recovery.

Antibiotic Dosing in Obesity

This is a clinically important point that is frequently overlooked:
DrugStandard DoseObese Patient Consideration
Amoxicillin-clavulanate875/125 mg BDStandard dosing generally adequate (hydrophilic, weight-independent)
Flucloxacillin1-2g IV 4-6 hourlyStandard
Piperacillin-tazobactam4.5g IV 8 hourlyMay need 4.5g IV 6 hourly in obesity due to larger Vd
Vancomycin15-20 mg/kgDose on ACTUAL body weight - obese patients need higher absolute doses; TDM (trough/AUC monitoring) is mandatory
Meropenem1g IV 8 hourlyStandard dosing adequate; extended infusion (over 3h) preferred in severe infection
Metronidazole500 mg IV 8 hourlyStandard - limited data on obesity adjustment; use standard dose
Gentamicin/AmikacinWeight-basedDose on adjusted body weight (IBW + 40% of excess body weight); monitor levels closely to avoid nephrotoxicity

Surgical Considerations in an Obese Patient

IssueRelevance
Anaesthetic riskHigher risk with obesity - difficult airway, OSA, positioning challenges; anaesthetics must be informed early
Wound closurePrimary closure under tension in obese patients risks dehiscence - may need retention sutures, staged closure, or negative pressure wound therapy (NPWT/VAC)
Drain placementIf abscess drained, drain may need to be longer to traverse adipose tissue; consider USS-guided placement
Laparoscopic urachal excisionTechnically more challenging in obesity but remains preferred over open; higher port placement may be needed
Necrotizing fasciitis debridementGreater extent of tissue involvement expected; plan for wide margins; plastic surgery input for reconstruction
DVT prophylaxisObese patients are at higher VTE risk, especially post-operative or immobilized - use LMWH (enoxaparin - dose on actual body weight: 0.5 mg/kg BD for prophylaxis) + compression stockings

Specific Management Algorithm for This Patient

23M, Obese, Non-Diabetic, Normotensive + Omphalitis
                        │
        ┌───────────────┴──────────────────┐
        │ Is there crepitus / disproportionate │
        │ pain / rapid spread / bullae / shock?│
        └───────────────┬──────────────────┘
              YES ──────┘──────── NO
               │                   │
    Necrotizing Fasciitis     Assess severity
    → EMERGENCY SURGERY        │
    → IV Meropenem +          ┌──┴────────────┐
      Vancomycin +            │               │
      Clindamycin          Mild           Moderate/Severe
    → Surgical team          │               │
      immediately         Outpatient    Admit + USS/CT
                          antibiotics    IV antibiotics
                                           │
                                   Abscess present?
                                      │        │
                                     YES       NO
                                   I&D      Continue IV
                                      │
                              Urachal remnant on imaging?
                                      │
                                     YES
                              Stage 1: Treat infection
                              Stage 2: Laparoscopic
                                      urachal excision
                                      (after ~2 months)

Long-Term Advice for This Patient

  1. Weight management is treatment, not just advice. Recurrence risk is directly tied to persistent obesity. Refer to a dietitian and consider bariatric evaluation if BMI is extreme.
  2. Daily umbilical hygiene: Teach the patient to clean inside the umbilical recess daily with a cotton bud and mild soap, rinse, and dry thoroughly.
  3. Screen for metabolic syndrome: Obese non-diabetic patients frequently progress to T2DM within years - annual HbA1c monitoring.
  4. Follow-up imaging: Given his age, sex, and obesity, ensure urachal remnant is excluded before discharge. If found, plan elective laparoscopic excision to prevent recurrence.
  5. Warn about warning signs: Teach the patient to return immediately if redness spreads rapidly, pain increases sharply, skin changes color, or he develops fever/chills - these suggest necrotizing fasciitis.

Bottom line for this patient: Obesity is the dominant modifiable risk factor driving his omphalitis. It creates the anatomical nidus (deep, moist, occluded umbilical recess), impairs local immunity, increases the risk of deep/necrotizing spread, and complicates both medical (drug dosing) and surgical management. The absence of diabetes does not eliminate his risk - obese adults have impaired neutrophil function and wound healing through non-glycaemic mechanisms. A urachal remnant must be actively excluded with imaging given his age and sex (>30% prevalence in this demographic), and if found, staged surgical excision is indicated to prevent recurrence.
This is a shared conversation. Sign in to Orris to start your own chat.